Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

421 ARTÍCULOS , VIENDO DEL 181 AL 195

The diagnostic accuracy of dopamine transporter SPECT imaging to detect nigrostriatal cell loss in patients with Parkinson's disease or clinically uncertain parkinsonism: a systematic review

Suwijn SR, van Boheemen CJ, de Haan RJ, Tissingh G, Booij J, de Bie RM.

EJNMMI Res. 2015 Mar 17;5:12. doi: 10.1186/s13550-015-0087-1. eCollection 2015.

Amyloid deposition in Parkinson's disease and cognitive impairment: a systematic review

Petrou M, Dwamena BA, Foerster BR, MacEachern MP, Bohnen NI, Müller ML, Albin RL, Frey KA.

Mov Disord. 2015 Jun;30(7):928-35. doi: 10.1002/mds.26191. Epub 2015 Apr 16.

Bilateral Parkinsonism: when to image?

Levi V, Bertani GA, Carrabba G, Locatelli M, Cogiamanian F, Rampini P.

Pract Neurol. 2015 Aug;15(4):300-1. doi: 10.1136/practneurol-2015-001083. Epub 2015 Apr 21.

Rivastigmine for mild cognitive impairment in Parkinson disease: a placebo-controlled study

Mamikonyan E, Xie SX, Melvin E, Weintraub D.

Mov Disord. 2015 Jun;30(7):912-8. doi: 10.1002/mds.26236. Epub 2015 Apr 25.

Relationship between the non-motor items of the MDS-UPDRS and Quality of Life in patients with Parkinson's disease

Skorvanek M, Rosenberger J, Minar M, Grofik M, Han V, Groothoff JW, Valkovic P, Gdovinova Z, van Dijk JP.

J Neurol Sci. 2015;353(1-2):87-91. doi: 10.1016/j.jns.2015.04.013. Epub 2015 Apr 17.

Mitochondrial Dysfunction and α-Synuclein Synaptic Pathology in Parkinson's Disease: Who's on First?

Zaltieri M, Longhena F, Pizzi M, Missale C, Spano P, Bellucci A.

Parkinsons Dis. 2015;2015:108029. doi: 10.1155/2015/108029. Epub 2015 Mar 31.

PET imaging in neurology: Alzheimer's and Parkinson's diseases

Sarikaya I.

Nucl Med Commun. 2015 Aug;36(8):775-81. doi: 10.1097/MNM.0000000000000320.

Multicenter Semiquantitative Evaluation of (123)I-FP-CIT Brain SPECT

Skanjeti A, Castellano G, Elia BO, Zotta M, Dazzara F, Manfredi M, Galati A, Grimaldi S, Balma M, Pellerito RE, Podio V.

J Neuroimaging. 2015 Nov-Dec;25(6):1023-9. doi: 10.1111/jon.12242. Epub 2015 Apr 29.

Association of cognitive domains with postural instability/gait disturbance in Parkinson's disease

Kelly VE, Johnson CO, McGough EL, Shumway-Cook A, Horak FB, Chung KA, Espay AJ, Revilla FJ, Devoto J, Wood-Siverio C, Factor SA, Cholerton B, Edwards KL, Peterson AL, Quinn JF, Montine TJ, Zabetian CP, Leverenz JB.

Parkinsonism Relat Disord. 2015 Jul;21(7):692-7. doi: 10.1016/j.parkreldis.2015.04.002. Epub 2015 Apr 14.

Clinically meaningful parameters of progression and long-term outcome of Parkinson disease: An international consensus statement

Puschmann A, Brighina L, Markopoulou K, Aasly J, Chung SJ, Frigerio R, Hadjigeorgiou G, Kõks S, Krüger R, Siuda J, Wider C, Zesiewicz TA, Maraganore DM.

Parkinsonism Relat Disord. 2015 Jul;21(7):675-82. doi: 10.1016/j.parkreldis.2015.04.029. Epub 2015 May 1.

Approach to the patient with Parkinson disease

Johnson KE.

Prim Care. 2015 Jun;42(2):205-15. doi: 10.1016/j.pop.2015.01.005. Epub 2015 Mar 5.

Vascular Parkinsonism: deconstructing a syndrome

Vizcarra JA, Lang AE, Sethi KD, Espay AJ.

Mov Disord. 2015 Jun;30(7):886-94. doi: 10.1002/mds.26263. Epub 2015 May 21.

Neuroimaging correlates of cognitive impairment and dementia in Parkinson's disease

Mak E, Su L, Williams GB, O'Brien JT.

Parkinsonism Relat Disord. 2015 Aug;21(8):862-70. doi: 10.1016/j.parkreldis.2015.05.013. Epub 2015 May 19.

Developments in the role of transcranial sonography for the differential diagnosis of parkinsonism

Pilotto A, Yilmaz R, Berg D.

Curr Neurol Neurosci Rep. 2015 Jul;15(7):43. doi: 10.1007/s11910-015-0566-9.

Deep brain stimulation for psychiatric disorders: where we are now

Cleary DR, Ozpinar A, Raslan AM, Ko AL.

Neurosurg Focus. 2015 Jun;38(6):E2. doi: 10.3171/2015.3.FOCUS1546.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias